Advanced search
Publication Cover
Cell Cycle Volume 17, 2018 - Issue 4
Submit an article Journal homepage
1,662
Views
33
CrossRef citations to date
0
Altmetric
Reports

SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell

Chenzhe FengDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, China;Xiangya School of Medicine, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Fang MaDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Chunhong HuDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Jin-an MaDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Jingjing WangDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Yang ZhangDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Fang WuDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Tao HouDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Shun JiangDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
,
Yapeng WangDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaView further author information
&
Yeqian FengDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, ChinaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7964-6784View further author information
ORCID Icon show all
Pages 448-458 | Received 14 Jun 2017, Accepted 17 Oct 2017, Published online: 08 Feb 2018

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shanshan Wang, Ming-Yue Li, Yi Liu, Alexander C Vlantis, Jason YK Chan, Lingbin Xue, Bao-Guang Hu, Shucai Yang, Mo-Xian Chen, Shaoming Zhou, Wei Guo, Xianhai Zeng, Shuqi Qiu, C Andrew van Hasselt, Michael CF Tong & George G Chen. (2020) The role of microRNA in cisplatin resistance or sensitivity. Expert Opinion on Therapeutic Targets 24:9, pages 885-897.
Read now

Articles from other publishers (32)

Qian Feng, Nan Cui, Shan Li, Jing Cao, Qian Chen & Haiyan Wang. (2023) Upregulation of SOX9 promotes the self‐renewal and tumorigenicity of cervical cancer through activating the Wnt/β‐catenin signaling pathway. The FASEB Journal 37:10.
Crossref
Mai A. Abd-Elmawla, Sherif S. Abdel Mageed, Tohada M. AL-Noshokaty, Mohammed S. Elballal, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Ahmed A. El-Husseiny, Doaa Fathi, Heba M. Midan, Nehal I. Rizk, Mahmoud A. Elrebehy, Ghadir A. Sayed, Manar Mohammed El Tabaa, Aya Salman, Osama A. Mohammed, Alaa Ashraf, Emad Gamil Khidr, Reem Khaled, Walaa A. El-Dakroury, Gouda Kamel Helal, Yasser M. Moustafa & Ahmed S. Doghish. (2023) Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma. Pathology - Research and Practice 250, pages 154817.
Crossref
Prerna Pandey, Geetika Suyal, Aprajita, Kiran Pasbola & Rinu Sharma. (2023) NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells. Functional & Integrative Genomics 23:2.
Crossref
Yangan Huo, Qiqi Li, Liu Yang, Xiaoxue Li, Chen Sun, Yang Liu, Honglin Liu, Zengxiang Pan, Qifa Li & Xing Du. (2023) SDNOR, a Novel Antioxidative lncRNA, Is Essential for Maintaining the Normal State and Function of Porcine Follicular Granulosa Cells. Antioxidants 12:4, pages 799.
Crossref
Andrei Havasi, Simona Sorana Cainap, Ana Teodora Havasi & Calin Cainap. (2023) Ovarian Cancer—Insights into Platinum Resistance and Overcoming It. Medicina 59:3, pages 544.
Crossref
Chao Guo, Shuhuang Zhou, Weimin Yi, Pingzhou Yang, Ou Li, Jianming Liu & Chuang Peng. (2022) SOX9/MKLN1-AS Axis Induces Hepatocellular Carcinoma Proliferation and Epithelial–Mesenchymal Transition. Biochemical Genetics 60:6, pages 1914-1933.
Crossref
Maria P. Morgan, Ellen Finnegan & Sudipto Das. (2022) The role of transcription factors in the acquisition of the four latest proposed hallmarks of cancer and corresponding enabling characteristics. Seminars in Cancer Biology 86, pages 1203-1215.
Crossref
Surya Kant Tripathi, Rajeev Kumar Sahoo & Bijesh Kumar Biswal. (2022) SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance. Drug Discovery Today 27:9, pages 2541-2550.
Crossref
Pengpeng Zhang, Bohan Li, Qianfeng Chen, Hui Wang & Qing Feng. (2022) Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC. Cancer Letters 543, pages 215793.
Crossref
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, Luis Felipe Ribeiro Pinto, Nathalia Meireles Da Costa & Antonio PalumboJrJr. (2022) Molecular mechanisms associated with chemoresistance in esophageal cancer. Cellular and Molecular Life Sciences 79:2.
Crossref
Shasha He, Yeqian Feng, Wen Zou, Jingjing Wang, Guiyuan Li, Wei Xiong, Yangchun Xie, Jin-an Ma & Xianling Liu. (2022) The Role of the SOX9/lncRNA ANXA2P2/miR-361-3p/SOX9 Regulatory Loop in Cervical Cancer Cell Growth and Resistance to Cisplatin. Frontiers in Oncology 11.
Crossref
Zhaoxia Wang, Fengyan Li, Simin He, Le Zhao & Fuyuan Wang. (2022) Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer. Gene 809, pages 146003.
Crossref
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Mohammad Hossein Gholami, Ali Zarrabi, Amirhossein Zabolian, Mehrdad Hashemi, Kiavash Hushmandi, Milad Ashrafizadeh, Amir Reza Aref & Saeed Samarghandian. (2021) Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies. Biomedicine & Pharmacotherapy 144, pages 112335.
Crossref
Tandrima Mitra & Selvakumar Elangovan. (2021) Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA. Molecular and Cellular Biochemistry 476:12, pages 4363-4385.
Crossref
Huan Chen, Yujie He, Xiangping Wen, Shihong Shao, Yujie Liu & Jinjin Wang. (2021) SOX9: Advances in Gynecological Malignancies. Frontiers in Oncology 11.
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, Amirhossein Zabolian, Hossein Saleki, Negar Azami, Atefe Kazemzade Bejandi, Sepideh Mirzaei, Milad Nemati Janaghard, Kiavash Hushmandi, Noushin Nabavi, Behzad Baradaran, Alan Prem Kumar, Pooyan Makvandi, Saeed Samarghandian, Haroon Khan & Michael R. Hamblin. (2021) Interplay between SOX9 transcription factor and microRNAs in cancer. International Journal of Biological Macromolecules 183, pages 681-694.
Crossref
Farzaneh Karimi & Homa Mollaei. (2021) Potential of miRNAs in cervical cancer chemoresistance. Gene Reports 23, pages 101109.
Crossref
Juanhong Zhao, Haixia Li & Miao Yuan. (2021) EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression. Genes & Genomics 43:5, pages 459-470.
Crossref
Marloes IJff, Gregor G. W. van Bochove, Denise Whitton, Roy Winiarczyk, Celina Honhoff, Hans Rodermond, Johannes Crezee, Lukas J. A. Stalpers, Nicolaas A. P. Franken & Arlene L. Oei. (2021) PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation. Cancers 13:9, pages 2092.
Crossref
Xueqin Zou, Yangjing Zhao, Xiuting Liang, Hui Wang, Yanling Zhu & Qixiang Shao. (2021) Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape. Frontiers in Immunology 12.
Crossref
Munmun Panda, Surya Kant Tripathi & Bijesh K. Biswal. (2021) SOX9: An emerging driving factor from cancer progression to drug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:2, pages 188517.
Crossref
Rina Masadah, Syahrul Rauf, Muhammad Yogi Pratama, Claudio Tiribelli & Devis Pascut. (2021) The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer. Cancers 13:5, pages 1168.
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, Kiavash Hushmandi, Azadeh Hakimi, Amirhossein Zabolian, Salman Daneshi, Saeed Samarghandian, Behzad Baradaran & Masoud Najafi. (2021) MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity. European Journal of Pharmacology 892, pages 173660.
Crossref
Luna Acharya, Hariharasudan Mani, Aman Ullah, Sana Hussain, Saeed Ali & Sarfraz Ahmad. 2021. Overcoming Drug Resistance in Gynecologic Cancers. Overcoming Drug Resistance in Gynecologic Cancers 49 75 .
Koji Yamanoi & Masaki Mandai. 2021. Molecular Diagnosis and Targeting for Gynecologic Malignancy. Molecular Diagnosis and Targeting for Gynecologic Malignancy 79 94 .
Sabine Stöckl, Georg Lindner, Shushan Li, Philipp Schuster, Sebastian Haferkamp, Ferdinand Wagner, Peter M. Prodinger, Gabriele Multhoff, Melanie Boxberg, Axel Hillmann, Richard J. Bauer & Susanne Grässel. (2020) SOX9 Knockout Induces Polyploidy and Changes Sensitivity to Tumor Treatment Strategies in a Chondrosarcoma Cell Line. International Journal of Molecular Sciences 21:20, pages 7627.
Crossref
Cui Li, Liping Li, Yaodong Yi, Wei Wang, Jingqun Yuan, Fuqing Tan, Danbo Fang, Su Zeng, Hui Zhou & Huidi Jiang. (2020) L-tetrahydropalmatine attenuates cisplatin-induced nephrotoxicity via selective inhibition of organic cation transporter 2 without impairing its antitumor efficacy. Biochemical Pharmacology 177, pages 114021.
Crossref
Xin Wen, Shui Liu, Jiyao Sheng & Manhua Cui. (2020) Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer. PeerJ 8, pages e9234.
Crossref
Cheng Cheng, Qiuyue Ding, Zhicai Zhang, Shangyu Wang, Binlong Zhong, Xin Huang & Zengwu Shao. (2020) PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1. Journal of Cellular and Molecular Medicine 24:9, pages 5274-5289.
Crossref
Yufan Zhou, Yun Huang, Kuan Hu, Zeyu Zhang, Jiajin Yang & Zhiming Wang. (2020) HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p. Cell Death & Disease 11:3.
Crossref
Xiaoli Wei, Mengru Gao, Yaser Ahmed, Min Gao, Wenbo Liu, Yiyin Zhang, Xiaoque Xie, Qihong Zhao, Hua Wang & Kangsheng Gu. (2019) MicroRNA‑362‑5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein. Oncology Letters.
Crossref
Yu Wang, Chun-ye Zhang, Rong-hui Xia, Jing Han, Bao Sun, Shu-yang Sun & Jiang Li. (2018) The MYB/miR-130a/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma. Cell Death & Disease 9:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.